Stay updated with breaking news from Reshape Vest. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ReShape Lifesciences (NASDAQ:RSLS – Get Free Report) and ICU Medical (NASDAQ:ICUI – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, dividends, risk, institutional ownership and valuation. Risk and Volatility ReShape Lifesciences has a beta […]
ReShape Lifesciences Inc. (NASDAQ:RSLS – Get Free Report) was the recipient of a large decline in short interest in April. As of April 15th, there was short interest totalling 487,800 shares, a decline of 33.1% from the March 31st total of 729,300 shares. Based on an average daily volume of 520,900 shares, the short-interest ratio […]
Vivos Therapeutics (NASDAQ:VVOS – Get Free Report) and ReShape Lifesciences (NASDAQ:RSLS – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, analyst recommendations, dividends, risk and institutional ownership. Profitability This table compares Vivos Therapeutics and […]
ReShape Lifesciences (NASDAQ:RSLS – Get Free Report) and Vivos Therapeutics (NASDAQ:VVOS – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk. Profitability This table compares ReShape Lifesciences and […]
ReShape Lifesciences Inc. (OTCMKTS:RSLSD – Get Free Report) shares traded up 2.3% on Monday . The company traded as high as $5.37 and last traded at $5.37. 6,500 shares traded hands during mid-day trading, an increase of 377% from the average session volume of 1,362 shares. The stock had previously closed at $5.25. ReShape Lifesciences […]